Reasons to attend
It is nowadays well recognized that Market Access represents a fourth hurdle after the three first ones of the registration step. Having a Marketing Authorization is not sufficient anymore to access the market. Strong data supporting the relative therapeutic value and economic value of new medicine are mandatory for a successful market and patient access.
This course will provide the basics of a market access plan, from early clinical development until the first EU launch. After the course, value proposition development, pricing strategy and some other aspects of the market access process will not be a secret anymore for the attendees.The course includes cases studies, short exercises and a final evaluation to encourage understanding.
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
- This course has been granted PharmaTrain Recognition
Course scheduleHalf day to 1 day